25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AXDX (Accelerate Diagnostics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Accelerate Diagnostics Inc together

I guess you are interested in Accelerate Diagnostics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Accelerate Diagnostics Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Accelerate Diagnostics Inc’s Price Targets

I'm going to help you getting a better view of Accelerate Diagnostics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Accelerate Diagnostics Inc

I send you an email if I find something interesting about Accelerate Diagnostics Inc.

1. Quick Overview

1.1. Quick analysis of Accelerate Diagnostics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Accelerate Diagnostics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
$-2.22
Expected worth in 1 year
$-3.41
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-1.20
Return On Investment
-2,991.1%

For what price can you sell your share?

Current Price per Share
$0.04
Expected price per share
$0 - $0.73
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Accelerate Diagnostics Inc (5 min.)




Live pricePrice per Share (EOD)
$0.04
Intrinsic Value Per Share
$-13.14 - $5.53
Total Value Per Share
$-15.35 - $3.31

2.2. Growth of Accelerate Diagnostics Inc (5 min.)




Is Accelerate Diagnostics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$56m-$29.8m-$19m-38.9%

How much money is Accelerate Diagnostics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$11.3m-$13m$1.7m15.2%
Net Profit Margin-390.3%-445.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Accelerate Diagnostics Inc (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#294 / 298

Most Revenue
#224 / 298

Most Profit
#247 / 298

Most Efficient
#257 / 298
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Accelerate Diagnostics Inc?

Welcome investor! Accelerate Diagnostics Inc's management wants to use your money to grow the business. In return you get a share of Accelerate Diagnostics Inc.

First you should know what it really means to hold a share of Accelerate Diagnostics Inc. And how you can make/lose money.

Speculation

The Price per Share of Accelerate Diagnostics Inc is $0.04. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Accelerate Diagnostics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Accelerate Diagnostics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-2.22. Based on the TTM, the Book Value Change Per Share is $-0.30 per quarter. Based on the YOY, the Book Value Change Per Share is $0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Accelerate Diagnostics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.38-947.8%-0.45-1,122.0%-0.58-1,459.3%-0.56-1,405.8%-0.63-1,578.8%-0.67-1,681.4%
Usd Book Value Change Per Share0.000.0%-0.30-747.8%0.13319.9%0.006.1%-0.07-163.6%-0.11-283.8%
Usd Dividend Per Share0.000.0%0.000.0%0.0137.3%0.0116.2%0.0011.3%0.005.7%
Usd Total Gains Per Share0.000.0%-0.30-747.8%0.14357.2%0.0122.3%-0.06-152.2%-0.11-278.2%
Usd Price Per Share0.70-1.20-2.87-1.68-4.12-12.25-
Price to Earnings Ratio-0.46--0.66-9.36-2.78-0.57--3.49-
Price-to-Total Gains Ratio-3.48-93.05-32.25-10.62--12.73-
Price to Book Ratio-0.32--0.65--2.66--1.57--2.59-1.44-
Price-to-Total Gains Ratio-3.48-93.05-32.25-10.62--12.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.04
Number of shares25000
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.30-0.07
Usd Total Gains Per Share-0.30-0.06
Gains per Quarter (25000 shares)-7,477.75-1,522.39
Gains per Year (25000 shares)-29,911.00-6,089.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-29911-29921454-6543-6100
20-59822-59832907-13087-12190
30-89733-897431361-19630-18280
40-119644-1196541815-26173-24370
50-149555-1495652269-32716-30460
60-179466-1794762722-39260-36550
70-209377-2093873176-45803-42640
80-239288-2392983630-52346-48730
90-269199-2692094083-58889-54820
100-299110-2991204537-65433-60910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%18.0100.00.015.3%
Book Value Change Per Share0.03.01.00.0%4.07.01.033.3%6.013.01.030.0%8.031.01.020.0%30.086.02.025.4%
Dividend per Share0.00.04.00.0%3.00.09.025.0%4.00.016.020.0%4.00.036.010.0%8.00.0110.06.8%
Total Gains per Share0.03.01.00.0%4.07.01.033.3%6.013.01.030.0%8.031.01.020.0%31.085.02.026.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Accelerate Diagnostics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.2990%0.128-100%0.002-100%-0.0650%-0.1140%
Book Value Per Share---2.216-1.932-13%-1.180-47%-1.475-33%-1.710-23%0.589-476%
Current Ratio--0.7131.052-32%1.294-45%1.855-62%5.239-86%13.311-95%
Debt To Asset Ratio--2.9622.738+8%1.785+66%2.031+46%1.851+60%1.120+164%
Debt To Equity Ratio----0%-0%-0%-0%0.708-100%
Dividend Per Share----0%0.015-100%0.006-100%0.005-100%0.002-100%
Enterprise Value---50569518.300-31192345.575-38%25066949.750-302%-11594916.543-77%41295008.025-222%307450270.887-116%
Eps---0.379-0.449+18%-0.584+54%-0.562+48%-0.632+67%-0.673+77%
Ev To Ebitda Ratio--2.8981.529+89%-0.651+122%0.450+544%-0.684+124%-4.945+271%
Ev To Sales Ratio---4.489-2.726-39%1.885-338%-1.005-78%3.898-215%951.854-100%
Free Cash Flow Per Share---0.200-0.206+3%-0.364+82%-0.353+76%-0.399+99%-0.493+146%
Free Cash Flow To Equity Per Share---0.224-0.057-74%-0.161-28%-0.132-41%-0.161-28%-0.047-79%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--5.526----------
Intrinsic Value_10Y_min---13.135----------
Intrinsic Value_1Y_max---1.130----------
Intrinsic Value_1Y_min---1.873----------
Intrinsic Value_3Y_max---2.112----------
Intrinsic Value_3Y_min---5.180----------
Intrinsic Value_5Y_max---1.547----------
Intrinsic Value_5Y_min---7.968----------
Market Cap1011668.000-1653%17729481.70030229904.425-41%72523949.750-76%42510500.124-58%104252008.025-83%309943270.887-94%
Net Profit Margin---3.405-3.903+15%-4.456+31%-4.582+35%-5.332+57%-94.667+2680%
Operating Margin---1.836-2.600+42%-5.596+205%-4.359+137%-4.719+157%-93.871+5013%
Operating Ratio--3.8173.853-1%4.956-23%4.947-23%5.696-33%178.688-98%
Pb Ratio-0.018+94%-0.316-0.650+105%-2.659+741%-1.569+396%-2.594+720%1.438-122%
Pe Ratio-0.026+94%-0.462-0.658+42%9.362-105%2.776-117%0.574-180%-3.486+654%
Price Per Share0.040-1653%0.7011.195-41%2.868-76%1.681-58%4.122-83%12.255-94%
Price To Free Cash Flow Ratio-0.050+94%-0.875-1.713+96%-2.088+139%-1.432+64%-2.599+197%-5.835+567%
Quick Ratio--0.6260.880-29%0.972-36%1.941-68%6.342-90%18.489-97%
Return On Assets---0.336-0.408+21%-0.344+2%-0.342+2%-0.286-15%-0.217-36%
Return On Equity----0%-0%-0%-0%-0.1580%
Total Gains Per Share----0.2990%0.143-100%0.009-100%-0.0610%-0.1110%
Usd Book Value---56040000.000-48862000.000-13%-29841000.000-47%-37296833.333-33%-43237000.000-23%14908125.000-476%
Usd Book Value Change Per Share----0.2990%0.128-100%0.002-100%-0.0650%-0.1140%
Usd Book Value Per Share---2.216-1.932-13%-1.180-47%-1.475-33%-1.710-23%0.589-476%
Usd Dividend Per Share----0%0.015-100%0.006-100%0.005-100%0.002-100%
Usd Enterprise Value---50569518.300-31192345.575-38%25066949.750-302%-11594916.543-77%41295008.025-222%307450270.887-116%
Usd Eps---0.379-0.449+18%-0.584+54%-0.562+48%-0.632+67%-0.673+77%
Usd Free Cash Flow---5068000.000-5201500.000+3%-9204500.000+82%-8936000.000+76%-10096600.000+99%-12474875.000+146%
Usd Free Cash Flow Per Share---0.200-0.206+3%-0.364+82%-0.353+76%-0.399+99%-0.493+146%
Usd Free Cash Flow To Equity Per Share---0.224-0.057-74%-0.161-28%-0.132-41%-0.161-28%-0.047-79%
Usd Market Cap1011668.000-1653%17729481.70030229904.425-41%72523949.750-76%42510500.124-58%104252008.025-83%309943270.887-94%
Usd Price Per Share0.040-1653%0.7011.195-41%2.868-76%1.681-58%4.122-83%12.255-94%
Usd Profit---9589000.000-11351250.000+18%-13075000.000+36%-13725666.667+43%-15589200.000+63%-16818150.000+75%
Usd Revenue--2816000.0002898250.000-3%3035250.000-7%3028250.000-7%2995000.000-6%2044100.000+38%
Usd Total Gains Per Share----0.2990%0.143-100%0.009-100%-0.0610%-0.1110%
 EOD+1 -6MRQTTM+12 -18YOY+13 -233Y+13 -235Y+12 -2010Y+14 -20

3.3 Fundamental Score

Let's check the fundamental score of Accelerate Diagnostics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.026
Price to Book Ratio (EOD)Between0-1-0.018
Net Profit Margin (MRQ)Greater than0-3.405
Operating Margin (MRQ)Greater than0-1.836
Quick Ratio (MRQ)Greater than10.626
Current Ratio (MRQ)Greater than10.713
Debt to Asset Ratio (MRQ)Less than12.962
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.336
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Accelerate Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5013.153
Ma 20Greater thanMa 500.402
Ma 50Greater thanMa 1000.679
Ma 100Greater thanMa 2000.928
OpenGreater thanClose0.015
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Accelerate Diagnostics Inc

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States and internationally. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing (AST) of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides Accelerate PhenoTest BC Kit, a test kit for the system, which is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. In addition, the company offers Accelerate Arc system, an instrument and associated one-time-use test kit that automates the clean-up and concentration of microbial cells from positive blood culture samples. Further, it develops Accelerate WAVE system, which performs AST directly from positive blood culture bottles and bacterial isolate colonies to report minimum inhibitory concentrations. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. On May 8, 2025, Accelerate Diagnostics, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Fundamental data was last updated by Penke on 2025-06-19 00:20:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Accelerate Diagnostics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Accelerate Diagnostics Inc to theΒ Medical Devices industry mean.
  • A Net Profit Margin of -340.5%Β means thatΒ $-3.41 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Accelerate Diagnostics Inc:

  • The MRQ is -340.5%. The company is making a huge loss. -2
  • The TTM is -390.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-340.5%TTM-390.3%+49.8%
TTM-390.3%YOY-445.6%+55.3%
TTM-390.3%5Y-533.2%+142.9%
5Y-533.2%10Y-9,466.7%+8,933.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-340.5%-7.7%-332.8%
TTM-390.3%-10.2%-380.1%
YOY-445.6%-10.9%-434.7%
3Y-458.2%-12.8%-445.4%
5Y-533.2%-10.3%-522.9%
10Y-9,466.7%-9.3%-9,457.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Accelerate Diagnostics Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Accelerate Diagnostics Inc to theΒ Medical Devices industry mean.
  • -33.6% Return on Assets means thatΒ Accelerate Diagnostics Inc generatedΒ $-0.34 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Accelerate Diagnostics Inc:

  • The MRQ is -33.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -40.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-33.6%TTM-40.8%+7.2%
TTM-40.8%YOY-34.4%-6.4%
TTM-40.8%5Y-28.6%-12.2%
5Y-28.6%10Y-21.7%-6.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-33.6%-2.1%-31.5%
TTM-40.8%-2.4%-38.4%
YOY-34.4%-3.1%-31.3%
3Y-34.2%-2.6%-31.6%
5Y-28.6%-2.6%-26.0%
10Y-21.7%-2.4%-19.3%
4.3.1.3. Return on Equity

Shows how efficient Accelerate Diagnostics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Accelerate Diagnostics Inc to theΒ Medical Devices industry mean.
  • 0.0% Return on Equity means Accelerate Diagnostics Inc generated $0.00Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Accelerate Diagnostics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-15.8%+15.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.9%+1.9%
TTM--2.6%+2.6%
YOY--2.6%+2.6%
3Y--3.7%+3.7%
5Y--4.2%+4.2%
10Y-15.8%-5.8%-10.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Accelerate Diagnostics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Accelerate Diagnostics Inc is operatingΒ .

  • Measures how much profit Accelerate Diagnostics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Accelerate Diagnostics Inc to theΒ Medical Devices industry mean.
  • An Operating Margin of -183.6%Β means the company generated $-1.84 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Accelerate Diagnostics Inc:

  • The MRQ is -183.6%. The company is operating very inefficient. -2
  • The TTM is -260.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-183.6%TTM-260.0%+76.4%
TTM-260.0%YOY-559.6%+299.7%
TTM-260.0%5Y-471.9%+212.0%
5Y-471.9%10Y-9,387.1%+8,915.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-183.6%-12.1%-171.5%
TTM-260.0%-13.6%-246.4%
YOY-559.6%-9.9%-549.7%
3Y-435.9%-9.6%-426.3%
5Y-471.9%-9.5%-462.4%
10Y-9,387.1%-9.4%-9,377.7%
4.3.2.2. Operating Ratio

Measures how efficient Accelerate Diagnostics Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Devices industry mean).
  • An Operation Ratio of 3.82 means that the operating costs are $3.82 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 3.817. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.853. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.817TTM3.853-0.036
TTM3.853YOY4.956-1.103
TTM3.8535Y5.696-1.842
5Y5.69610Y178.688-172.993
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8171.395+2.422
TTM3.8531.367+2.486
YOY4.9561.275+3.681
3Y4.9471.337+3.610
5Y5.6961.349+4.347
10Y178.6881.321+177.367
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Accelerate Diagnostics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Accelerate Diagnostics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Devices industry mean).
  • A Current Ratio of 0.71Β means the company has $0.71 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 0.713. The company is unable to pay all its short-term debts. -2
  • The TTM is 1.052. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.713TTM1.052-0.339
TTM1.052YOY1.294-0.241
TTM1.0525Y5.239-4.187
5Y5.23910Y13.311-8.072
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7132.516-1.803
TTM1.0522.611-1.559
YOY1.2942.651-1.357
3Y1.8552.949-1.094
5Y5.2393.539+1.700
10Y13.3113.302+10.009
4.4.3.2. Quick Ratio

Measures if Accelerate Diagnostics Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Accelerate Diagnostics Inc to theΒ Medical Devices industry mean.
  • A Quick Ratio of 0.63Β means the company can pay off $0.63 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 0.626. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.880. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.626TTM0.880-0.254
TTM0.880YOY0.972-0.092
TTM0.8805Y6.342-5.462
5Y6.34210Y18.489-12.147
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6261.107-0.481
TTM0.8801.412-0.532
YOY0.9721.652-0.680
3Y1.9411.816+0.125
5Y6.3422.145+4.197
10Y18.4892.350+16.139
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Accelerate Diagnostics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Accelerate Diagnostics IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Accelerate Diagnostics Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 2.96Β means that Accelerate Diagnostics Inc assets areΒ financed with 296.2% credit (debt) and the remaining percentage (100% - 296.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 2.962. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.738. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.962TTM2.738+0.225
TTM2.738YOY1.785+0.953
TTM2.7385Y1.851+0.886
5Y1.85110Y1.120+0.731
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9620.400+2.562
TTM2.7380.410+2.328
YOY1.7850.391+1.394
3Y2.0310.388+1.643
5Y1.8510.414+1.437
10Y1.1200.455+0.665
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Accelerate Diagnostics Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Accelerate Diagnostics Inc to theΒ Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Accelerate Diagnostics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.708-0.708
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.554-0.554
TTM-0.636-0.636
YOY-0.589-0.589
3Y-0.631-0.631
5Y-0.647-0.647
10Y0.7080.754-0.046
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Accelerate Diagnostics Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Accelerate Diagnostics Inc to theΒ Medical Devices industry mean.
  • A PE ratio of -0.46 means the investor is paying $-0.46Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Accelerate Diagnostics Inc:

  • The EOD is -0.026. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.462. Based on the earnings, the company is expensive. -2
  • The TTM is -0.658. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.026MRQ-0.462+0.436
MRQ-0.462TTM-0.658+0.195
TTM-0.658YOY9.362-10.020
TTM-0.6585Y0.574-1.232
5Y0.57410Y-3.486+4.060
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.026-1.153+1.127
MRQ-0.462-1.449+0.987
TTM-0.658-1.183+0.525
YOY9.362-1.829+11.191
3Y2.776-1.328+4.104
5Y0.574-1.482+2.056
10Y-3.486-1.435-2.051
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Accelerate Diagnostics Inc:

  • The EOD is -0.050. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.875. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.713. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.050MRQ-0.875+0.825
MRQ-0.875TTM-1.713+0.838
TTM-1.713YOY-2.088+0.375
TTM-1.7135Y-2.599+0.886
5Y-2.59910Y-5.835+3.236
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.050-2.438+2.388
MRQ-0.875-3.182+2.307
TTM-1.713-1.554-0.159
YOY-2.088-3.394+1.306
3Y-1.432-2.971+1.539
5Y-2.599-2.902+0.303
10Y-5.835-3.337-2.498
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Accelerate Diagnostics Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Devices industry mean).
  • A PB ratio of -0.32 means the investor is paying $-0.32Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Accelerate Diagnostics Inc:

  • The EOD is -0.018. Based on the equity, the company is expensive. -2
  • The MRQ is -0.316. Based on the equity, the company is expensive. -2
  • The TTM is -0.650. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.018MRQ-0.316+0.298
MRQ-0.316TTM-0.650+0.333
TTM-0.650YOY-2.659+2.010
TTM-0.6505Y-2.594+1.944
5Y-2.59410Y1.438-4.032
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0181.943-1.961
MRQ-0.3161.993-2.309
TTM-0.6502.254-2.904
YOY-2.6592.669-5.328
3Y-1.5692.718-4.287
5Y-2.5943.855-6.449
10Y1.4384.251-2.813
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Accelerate Diagnostics Inc.

4.8.1. Institutions holding Accelerate Diagnostics Inc

Institutions are holding 17.919% of the shares of Accelerate Diagnostics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Armistice Capital, LLC7.43020.01971879227-198773-9.5656
2025-03-31Hovey Youngman Associates Inc3.37280.0732853036-150545-15.0008
2025-03-31Vanguard Group Inc1.8903047809300
2025-03-31Lido Advisors, LLC0.64510.00051631611631610
2025-03-31Geode Capital Management, LLC0.5635014251867864.9996
2024-12-31Spears Abacus Advisors LLC0.45280.002811452300
2025-03-31Renaissance Technologies Corp0.25380.000164200-42862-40.0347
2025-03-31Tci Wealth Advisors Inc0.21980.00315558600
2025-03-31Susquehanna International Group, LLP0.21850552682561686.3888
2025-03-31BlackRock Inc0.20105084200
2025-03-31Cladis Investment Advisory LLC0.16880.02174270000
2024-12-31Belpointe Asset Management LLC0.13420.00413394100
2025-03-31Citadel Advisors Llc0.0927023451-11961-33.7767
2025-03-31State Street Corp0.080702041500
2025-03-31Ironwood Wealth Management, LLC0.08030.00312031300
2025-03-31TWO SIGMA SECURITIES, LLC0.07270.0021839514598.6148
2025-03-31Northern Trust Corp0.067016953-13070-43.5333
2025-03-31Tudor Investment Corp Et AL0.055801411000
2025-03-31Tejara Capital Ltd0.05160.003513056-84-0.6393
2025-03-31Hanson Mcclain Inc0.041101040000
Total 16.09270.13384070188-220273-5.4%

4.9.2. Funds holding Accelerate Diagnostics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv1.5082038145600
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr0.37690.00019533300
2025-04-30Fidelity Extended Market Index0.30340.000176735-733-0.9462
2025-04-30Fidelity Series Total Market Index0.074401882600
2024-12-31BANOR SICAV Rosemary S EUR Acc0.06760.06391710900
2025-04-30Fidelity Total Market Index0.059601506400
2025-04-30Spartan Extended Market Index Pool F0.04650.0001117557336.6503
2025-03-31Extended Equity Market Fund K0.04540.000111495350.3054
2025-03-31Thompson MidCap0.04110.01481039000
2025-04-30Spartan Total Market Index Pool G0.03630918000
2025-03-31NT Ext Equity Mkt Idx Fd - L0.0360.0001909300
2025-03-31Northern Trust Extended Eq Market Idx0.0360.0001909300
2025-04-30Fidelity Nasdaq Composite Index0.031207895-3024-27.6948
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.0270.0001682900
2025-03-31T. Rowe Price U.S. Equities Tr0.02530639000
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0210.00015316-97-1.792
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00860.00012184170.7845
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.00860.0001216721670
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.00860.0001216721670
2025-03-31Extended Equity Market Fund M0.00570.00011440-49-3.2908
Total 2.76740.0799699917+1216+0.2%

5.3. Insider Transactions

Insiders are holding 38.308% of the shares of Accelerate Diagnostics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-04-04Jack PhillipsSELL253430.65
2025-04-04Larry Michael MertzSELL15230.65
2025-04-01David PatienceSELL68160.71
2025-02-26David PatienceSELL5351.09
2024-12-03John PatienceBUY2000001.57
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets28,556
Total Liabilities84,596
Total Stockholder Equity-56,040
 As reported
Total Liabilities 84,596
Total Stockholder Equity+ -56,040
Total Assets = 28,556

Assets

Total Assets28,556
Total Current Assets22,238
Long-term Assets6,318
Total Current Assets
Cash And Cash Equivalents 15,098
Short-term Investments 1,199
Net Receivables 2,037
Inventory 2,852
Other Current Assets 1,052
Total Current Assets  (as reported)22,238
Total Current Assets  (calculated)22,238
+/-0
Long-term Assets
Property Plant Equipment 5,818
Long-term Assets Other 500
Long-term Assets  (as reported)6,318
Long-term Assets  (calculated)6,318
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities31,201
Long-term Liabilities53,395
Total Stockholder Equity-56,040
Total Current Liabilities
Short-term Debt 16,512
Accounts payable 4,844
Other Current Liabilities 8,207
Total Current Liabilities  (as reported)31,201
Total Current Liabilities  (calculated)29,563
+/- 1,638
Long-term Liabilities
Long-term Liabilities  (as reported)53,395
Long-term Liabilities  (calculated)0
+/- 53,395
Total Stockholder Equity
Accumulated Other Comprehensive Income -6
Other Stockholders Equity -56,034
Total Stockholder Equity (as reported)-56,040
Total Stockholder Equity (calculated)-56,040
+/-0
Other
Cash and Short Term Investments 16,297
Common Stock Shares Outstanding 23,302
Current Deferred Revenue1,638
Liabilities and Stockholders Equity 28,556
Net Debt 51,478
Net Working Capital -8,963
Short Long Term Debt Total 66,576



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-30
> Total Assets 
0
1,200
1,600
2,300
2,700
8,900
9,200
9,800
11,429
13,042
14,850
13,975
13,728
13,820
14,100
14,073
13,889
14,071
13,127
13,106
12,802
12,073
11,493
10,732
10,254
12,306
14,047
15,024
14,857
14,700
14,130
13,745
13,294
13,024
12,692
12,725
12,250
11,926
11,381
11,008
10,094
9,289
8,564
7,848
7,389
7,025
6,570
6,138
5,827
5,571
5,924
5,827
5,607
5,468
5,382
5,231
4,852
4,489
4,506
6,269
6,418
6,437
6,359
6,359
6,252
6,013
5,679
17,214
15,864
13,300
31,229
29,332
45,933
43,430
41,417
81,804
75,153
69,801
63,337
53,347
44,755
139,324
125,648
110,515
96,632
82,852
74,404
148,257
136,107
125,512
213,115
218,253
200,656
185,265
172,185
158,644
147,278
134,424
119,993
114,815
104,219
93,425
92,668
93,989
81,161
83,047
70,357
58,726
75,847
65,015
51,002
49,878
39,324
31,366
30,722
22,867
32,315
28,556
28,556
28,55628,55632,31522,86730,72231,36639,32449,87851,00265,01575,84758,72670,35783,04781,16193,98992,66893,425104,219114,815119,993134,424147,278158,644172,185185,265200,656218,253213,115125,512136,107148,25774,40482,85296,632110,515125,648139,32444,75553,34763,33769,80175,15381,80441,41743,43045,93329,33231,22913,30015,86417,2145,6796,0136,2526,3596,3596,4376,4186,2694,5064,4894,8525,2315,3825,4685,6075,8275,9245,5715,8276,1386,5707,0257,3897,8488,5649,28910,09411,00811,38111,92612,25012,72512,69213,02413,29413,74514,13014,70014,85715,02414,04712,30610,25410,73211,49312,07312,80213,10613,12714,07113,88914,07314,10013,82013,72813,97514,85013,04211,4299,8009,2008,9002,7002,3001,6001,2000
   > Total Current Assets 
0
1,000
1,300
2,000
2,300
8,600
8,700
9,000
10,406
11,791
13,348
12,026
11,508
11,402
11,652
11,658
11,554
11,571
11,038
11,123
10,950
10,207
9,931
9,652
9,165
8,881
8,719
9,879
9,701
9,611
9,039
8,773
8,292
8,052
7,712
7,504
7,018
6,731
6,194
6,131
5,199
4,444
3,780
3,084
2,582
2,279
1,883
1,532
1,149
1,009
1,410
1,376
1,194
1,140
1,086
943
530
211
258
751
939
913
863
863
1,387
1,180
868
15,042
13,968
12,800
30,142
28,113
44,634
42,143
39,571
79,668
72,698
67,098
59,664
49,433
40,920
134,151
120,276
105,403
91,681
78,448
70,349
143,273
131,280
120,488
207,135
212,608
192,884
177,640
164,000
150,174
134,395
121,852
106,744
102,508
92,039
81,987
81,811
83,695
71,516
73,331
61,111
48,059
66,272
56,014
42,834
42,239
32,443
24,466
24,133
17,170
27,436
22,238
22,238
22,23822,23827,43617,17024,13324,46632,44342,23942,83456,01466,27248,05961,11173,33171,51683,69581,81181,98792,039102,508106,744121,852134,395150,174164,000177,640192,884212,608207,135120,488131,280143,27370,34978,44891,681105,403120,276134,15140,92049,43359,66467,09872,69879,66839,57142,14344,63428,11330,14212,80013,96815,0428681,1801,3878638639139397512582115309431,0861,1401,1941,3761,4101,0091,1491,5321,8832,2792,5823,0843,7804,4445,1996,1316,1946,7317,0187,5047,7128,0528,2928,7739,0399,6119,7019,8798,7198,8819,1659,6529,93110,20710,95011,12311,03811,57111,55411,65811,65211,40211,50812,02613,34811,79110,4069,0008,7008,6002,3002,0001,3001,0000
       Cash And Cash Equivalents 
0
900
1,100
1,400
1,700
8,000
7,900
7,900
8,148
9,286
10,283
10,439
10,587
10,167
10,293
10,257
10,559
10,562
10,311
10,360
10,359
10,021
9,798
9,522
9,094
8,693
8,607
8,631
8,641
9,177
8,691
8,712
8,171
7,803
7,511
7,233
6,815
6,424
5,898
5,564
4,922
4,184
3,517
3,004
2,537
2,102
1,801
1,394
1,027
879
1,277
1,233
1,081
987
979
862
470
109
166
283
222
425
372
372
585
513
213
14,263
13,196
12,100
29,257
27,173
33,453
30,029
26,142
65,212
57,851
53,563
47,391
35,231
25,191
120,585
72,033
37,519
28,731
19,244
9,917
62,609
34,431
28,513
126,847
66,810
61,622
66,260
75,309
87,469
92,938
61,014
39,487
47,368
27,029
35,781
42,726
44,580
35,725
39,898
13,654
4,581
38,987
34,905
29,408
29,282
20,162
12,138
14,606
8,588
19,691
15,098
15,098
15,09815,09819,6918,58814,60612,13820,16229,28229,40834,90538,9874,58113,65439,89835,72544,58042,72635,78127,02947,36839,48761,01492,93887,46975,30966,26061,62266,810126,84728,51334,43162,6099,91719,24428,73137,51972,033120,58525,19135,23147,39153,56357,85165,21226,14230,02933,45327,17329,25712,10013,19614,2632135135853723724252222831661094708629799871,0811,2331,2778791,0271,3941,8012,1022,5373,0043,5174,1844,9225,5645,8986,4246,8157,2337,5117,8038,1718,7128,6919,1778,6418,6318,6078,6939,0949,5229,79810,02110,35910,36010,31110,56210,55910,25710,29310,16710,58710,43910,2839,2868,1487,9007,9008,0001,7001,4001,1009000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,960
11,959
12,420
13,800
14,081
13,115
11,061
13,030
13,840
11,839
44,630
64,919
61,422
58,519
54,029
72,609
86,889
80,648
66,754
130,594
118,982
100,218
75,550
50,349
28,978
47,437
52,525
41,326
50,463
32,488
23,954
24,251
21,299
23,720
36,722
32,191
16,407
10,656
2,457
1,423
989
1,081
1,145
1,158
1,221
1,199
1,199
1,1991,1991,2211,1581,1451,0819891,4232,45710,65616,40732,19136,72223,72021,29924,25123,95432,48850,46341,32652,52547,43728,97850,34975,550100,218118,982130,59466,75480,64886,88972,60954,02958,51961,42264,91944,63011,83913,84013,03011,06113,11514,08113,80012,42011,95910,960000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
100
200
400
400
300
600
900
1,946
2,188
2,763
1,415
752
1,065
1,132
1,122
688
566
300
277
498
92
59
69
29
99
33
1,186
874
81
262
6
19
115
75
199
146
190
187
311
23
8
7
11
9
121
17
6
6
11
6
6
6
50
50
0
50
15
20
416
672
417
428
428
761
596
600
751
753
800
794
818
106
24
40
40
89
78
92
143
742
77
77
169
159
34
551
682
1,111
1,946
1,065
1,823
1,440
1,860
1,950
1,911
2,642
3,222
3,143
2,592
2,610
1,550
1,976
2,114
2,269
2,320
2,114
2,935
2,393
2,416
2,427
2,342
2,666
2,622
2,217
2,289
2,027
2,037
2,037
2,0372,0372,0272,2892,2172,6222,6662,3422,4272,4162,3932,9352,1142,3202,2692,1141,9761,5502,6102,5923,1433,2222,6421,9111,9501,8601,4401,8231,0651,9461,11168255134159169777774214392788940402410681879480075375160059676142842841767241620155005050666116617121911782331118719014619975115196262818741,1863399296959924982773005666881,1221,1321,0657521,4152,7632,1881,9469006003004004002001000
       Other Current Assets 
0
0
0
200
200
300
200
200
313
317
301
171
169
170
227
279
307
443
427
486
92
91
71
61
40
90
80
62
186
354
86
55
33
65
62
41
30
84
85
228
226
226
231
43
13
27
35
24
13
19
35
39
15
25
38
28
16
50
37
19
11
37
32
21
11
41
25
18
19
6
92
244
115
130
969
616
677
342
1,120
1,029
1,147
12
3,536
2,796
1,369
183
1,495
1,653
1,508
468
804
643
1,434
576
2,592
2,147
1,956
1,165
3,062
2,499
2,478
1,780
3,370
3,178
2,491
1,558
1,594
1,619
1,974
2,025
1,575
2,812
5,073
5,315
2,916
1,912
1,519
2,251
1,052
1,0522,2511,5191,9122,9165,3155,0732,8121,5752,0251,9741,6191,5941,5582,4913,1783,3701,7802,4782,4993,0621,1651,9562,1472,5925761,4346438044681,5081,6531,4951831,3692,7963,536121,1471,0291,12034267761696913011524492619182541112132371119375016283825153935191324352713432312262262288584304162653355863541866280904061719192486427443307279227170169171301317313200200300200200000
   > Long-term Assets 
0
200
300
300
400
300
500
800
1,023
1,251
1,502
1,949
2,220
2,418
2,448
2,414
2,335
2,500
2,089
1,983
1,852
1,866
1,562
1,079
1,089
3,425
5,328
5,145
5,155
5,088
5,091
4,972
5,001
4,972
4,980
5,221
5,232
5,195
5,187
0
4,895
4,845
4,784
4,764
4,808
4,745
4,688
4,606
4,678
4,562
4,513
4,451
4,413
4,328
4,296
4,288
4,322
4,279
4,248
5,518
5,479
5,524
5,496
5,496
4,865
4,833
4,811
2,171
1,896
500
1,087
1,218
1,299
1,287
1,846
2,136
2,455
2,703
3,673
3,914
3,835
5,173
5,372
5,112
4,951
4,404
4,055
4,984
4,827
5,024
5,980
5,645
7,772
7,625
8,185
8,470
12,883
12,572
13,249
12,307
12,180
11,438
10,857
10,294
9,645
9,716
9,246
10,667
9,575
9,001
8,168
7,639
6,881
6,900
6,589
5,697
4,879
6,318
6,318
6,3186,3184,8795,6976,5896,9006,8817,6398,1689,0019,57510,6679,2469,7169,64510,29410,85711,43812,18012,30713,24912,57212,8838,4708,1857,6257,7725,6455,9805,0244,8274,9844,0554,4044,9515,1125,3725,1733,8353,9143,6732,7032,4552,1361,8461,2871,2991,2181,0875001,8962,1714,8114,8334,8655,4965,4965,5245,4795,5184,2484,2794,3224,2884,2964,3284,4134,4514,5134,5624,6784,6064,6884,7454,8084,7644,7844,8454,89505,1875,1955,2325,2214,9804,9725,0014,9725,0915,0885,1555,1455,3283,4251,0891,0791,5621,8661,8521,9832,0892,5002,3352,4142,4482,4182,2201,9491,5021,2511,0238005003004003003002000
       Property Plant Equipment 
0
100
100
100
100
100
100
200
173
234
249
293
306
288
271
258
241
228
197
180
162
213
162
82
76
70
65
77
70
78
81
142
132
127
204
217
205
201
247
231
235
221
200
180
162
144
125
107
92
61
49
37
32
26
20
15
12
10
7
4
5
5
4
4
3
2
2
4
73
148
777
930
1,039
1,047
1,624
1,933
2,270
2,536
3,508
3,752
3,676
5,016
5,218
4,960
4,802
4,258
3,912
4,844
4,690
4,890
5,851
5,443
7,412
7,303
7,729
7,999
12,400
11,822
12,381
11,573
10,506
9,318
8,832
8,396
7,822
7,899
7,455
8,816
7,952
7,759
7,073
6,514
5,768
5,084
5,379
4,815
4,116
5,818
5,818
5,8185,8184,1164,8155,3795,0845,7686,5147,0737,7597,9528,8167,4557,8997,8228,3968,8329,31810,50611,57312,38111,82212,4007,9997,7297,3037,4125,4435,8514,8904,6904,8443,9124,2584,8024,9605,2185,0163,6763,7523,5082,5362,2701,9331,6241,0471,0399307771487342234455471012152026323749619210712514416218020022123523124720120521720412713214281787077657076821622131621801972282412582712883062932492341732001001001001001001000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
482
2,799
4,217
4,623
0
0
4,470
4,256
4,205
4,153
4,104
4,071
4,018
3,975
3,929
3,879
3,820
3,761
3,701
3,712
3,652
3,592
3,532
3,472
3,447
3,400
3,371
3,347
3,288
3,246
3,204
3,170
3,120
3,070
3,017
2,968
2,920
2,861
2,823
2,788
1,377
1,394
1,414
1,486
193
193
310
288
260
241
222
203
185
167
165
162
159
157
154
152
149
146
143
140
137
134
129
124
119
114
108
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000001081141191241291341371401431461491521541571591621651671852032222412602883101931931,4861,4141,3941,3772,7882,8232,8612,9202,9683,0173,0703,1203,1703,2043,2463,2883,3473,3713,4003,4473,4723,5323,5923,6523,7123,7013,7613,8203,8793,9293,9754,0184,0714,1044,1534,2054,2564,470004,6234,2172,799482000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
747
745
743
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000007437457470000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
485
482
2,799
537
4,623
4,623
4,517
4,470
4,256
4,205
4,153
4,104
4,071
4,018
3,975
3,929
3,879
3,820
3,761
3,701
3,712
3,652
3,592
3,532
3,472
3,447
3,400
3,371
3,347
3,288
3,288
3,204
3,169
3,120
3,069
3,017
2,967
2,920
2,861
2,824
2,787
2,788
2,691
2,651
681
132
300
310
288
260
241
222
203
185
167
165
162
159
157
154
152
149
146
143
140
137
134
129
124
119
114
108
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000001081141191241291341371401431461491521541571591621651671852032222412602883103001326812,6512,6912,7882,7872,8242,8612,9202,9673,0173,0693,1203,1693,2043,2883,2883,3473,3713,4003,4473,4723,5323,5923,6523,7123,7013,7613,8203,8793,9293,9754,0184,0714,1044,1534,2054,2564,4704,5174,6234,6235372,79948248500000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,272
1,891
1,803
1,690
1,653
1,400
998
1,013
3,355
5,263
5,068
5,086
5,010
5,010
4,830
4,869
4,845
4,776
5,004
5,027
4,994
4,940
4,646
4,660
4,624
4,584
4,584
4,645
4,602
4,562
4,499
4,586
4,501
4,464
4,414
4,381
4,302
4,276
4,273
4,310
4,268
4,241
5,514
5,474
5,520
5,492
4,837
4,862
4,831
4,809
2,168
1,823
0
309
288
260
240
222
203
185
167
165
162
159
157
154
152
149
146
143
140
137
134
129
78
241
208
348
471
483
750
868
734
1,674
5,303
2,025
1,898
1,823
1,817
1,791
1,851
1,623
1,242
0
1,125
1,113
0
0
0
0
0
0
0000001,1131,12501,2421,6231,8511,7911,8171,8231,8982,0255,3031,6747348687504834713482082417812913413714014314614915215415715916216516718520322224026028830901,8232,1684,8094,8314,8624,8375,4925,5205,4745,5144,2414,2684,3104,2734,2764,3024,3814,4144,4644,5014,5864,4994,5624,6024,6454,5844,5844,6244,6604,6464,9404,9945,0275,0044,7764,8454,8694,8305,0105,0105,0865,0685,2633,3551,0139981,4001,6531,6901,8031,8912,27200000000000000000
> Total Liabilities 
0
200
200
400
500
400
300
600
1,408
1,522
2,172
1,619
1,398
1,420
1,837
1,837
1,841
2,110
1,725
1,844
1,732
1,361
1,133
1,120
902
854
821
1,279
1,333
1,363
911
1,016
987
1,093
1,137
988
1,023
1,014
1,032
1,340
1,180
1,161
1,211
1,109
1,182
1,259
1,275
1,258
1,415
1,480
1,374
1,414
1,322
1,307
1,400
1,337
1,361
1,371
1,412
1,359
1,432
1,474
1,514
1,514
1,594
1,663
1,658
2,378
2,425
1,200
1,136
1,807
939
1,914
2,608
3,100
2,876
3,810
4,515
3,997
4,568
6,306
5,987
5,474
5,449
5,036
5,271
6,223
6,183
6,808
106,640
123,367
123,250
127,890
129,217
132,639
137,058
141,803
142,935
151,805
153,887
156,237
159,032
163,739
120,908
118,118
127,133
120,690
85,644
87,279
89,727
88,541
74,357
51,254
56,502
57,754
80,796
84,596
84,596
84,59684,59680,79657,75456,50251,25474,35788,54189,72787,27985,644120,690127,133118,118120,908163,739159,032156,237153,887151,805142,935141,803137,058132,639129,217127,890123,250123,367106,6406,8086,1836,2235,2715,0365,4495,4745,9876,3064,5683,9974,5153,8102,8763,1002,6081,9149391,8071,1361,2002,4252,3781,6581,6631,5941,5141,5141,4741,4321,3591,4121,3711,3611,3371,4001,3071,3221,4141,3741,4801,4151,2581,2751,2591,1821,1091,2111,1611,1801,3401,0321,0141,0239881,1371,0939871,0169111,3631,3331,2798218549021,1201,1331,3611,7321,8441,7252,1101,8411,8371,8371,4201,3981,6192,1721,5221,4086003004005004002002000
   > Total Current Liabilities 
0
200
200
300
400
300
200
400
1,026
1,137
1,725
790
554
481
842
691
674
700
512
623
591
433
366
527
346
254
250
734
778
792
266
367
305
363
409
247
262
223
234
497
321
283
272
162
170
212
188
155
257
339
222
272
210
214
271
158
152
134
132
76
114
119
133
133
198
231
187
1,392
1,439
1,200
1,136
1,807
412
1,137
1,707
2,250
2,063
2,783
3,501
2,997
3,568
5,306
4,987
4,474
4,449
4,036
5,249
6,223
6,183
6,787
7,453
7,842
5,470
7,763
6,467
7,512
6,128
8,162
6,659
10,118
7,070
6,969
7,364
9,317
7,511
6,945
8,214
10,725
9,568
66,557
68,125
53,716
37,786
12,034
16,131
13,413
18,258
31,201
31,201
31,20131,20118,25813,41316,13112,03437,78653,71668,12566,5579,56810,7258,2146,9457,5119,3177,3646,9697,07010,1186,6598,1626,1287,5126,4677,7635,4707,8427,4536,7876,1836,2235,2494,0364,4494,4744,9875,3063,5682,9973,5012,7832,0632,2501,7071,1374121,8071,1361,2001,4391,392187231198133133119114761321341521582712142102722223392571551882121701622722833214972342232622474093633053672667927787342502543465273664335916235127006746918424815547901,7251,1371,0264002003004003002002000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
84
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31
0
0
0
0
0
0
47
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
143
145
146
147
124
87
50
13
0
0
0
0
0
0
0
0
99,162
115,499
0
0
488
400
842
450
906
3,023
1,475
1,050
2,229
2,676
1,642
749
857
1,769
1,807
58,355
58,590
2,842
2,157
2,286
2,351
1,208
922
16,512
16,512
16,51216,5129221,2082,3512,2862,1572,84258,59058,3551,8071,7698577491,6422,6762,2291,0501,4753,02390645084240048800115,49999,1620000000013508712414714614514300000000000000000000000000000000000004700000031000000000000000084000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
160
0
0
0
13
0
0
0
0
0
0
0
0
99,162
115,499
0
0
244
0
0
0
0
2,129
511
553
1,127
1,452
352
80
82
84
80
56,413
56,595
726
726
726
726
0
0
16,512
0
016,5120072672672672656,59556,413808482803521,4521,1275535112,129000024400115,49999,162000000001300016000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
100
100
100
100
100
246
185
196
402
249
150
202
223
233
313
210
184
247
216
177
153
154
101
105
88
129
146
104
177
173
160
191
97
116
75
109
153
180
171
147
72
93
94
69
65
116
124
78
134
67
98
126
39
34
65
60
32
64
76
95
34
57
101
50
63
84
300
29
322
7
540
718
1,302
1,102
2,129
2,364
1,741
1,552
2,623
2,673
1,789
2,400
992
1,263
1,534
1,369
2,080
2,758
2,355
1,559
1,322
2,505
1,819
2,281
2,351
3,401
2,702
2,372
1,290
1,917
1,877
2,330
1,983
2,717
2,221
2,819
4,501
3,524
4,033
4,812
4,796
5,108
3,759
4,714
4,844
4,844
4,8444,8444,7143,7595,1084,7964,8124,0333,5244,5012,8192,2212,7171,9832,3301,8771,9171,2902,3722,7023,4012,3512,2811,8192,5051,3221,5592,3552,7582,0801,3691,5341,2639922,4001,7892,6732,6231,5521,7412,3642,1291,1021,302718540732229300846350101573495766432606534391269867134781241166569949372147171180153109751169719116017317710414612988105101154153177216247184210313233223202150249402196185246100100100100100000
       Other Current Liabilities 
0
200
200
200
300
200
100
300
780
951
1,529
388
104
62
72
61
60
65
48
439
38
36
32
374
25
29
21
479
475
481
30
39
28
40
32
90
56
84
60
344
69
40
53
31
52
47
54
32
42
26
17
26
31
18
27
26
41
26
30
23
34
27
38
35
36
33
44
1,243
1,272
948
1,037
912
321
515
768
727
741
494
1,000
1,156
1,953
2,543
2,256
2,642
2,005
3,009
2,944
3,611
3,733
3,636
4,578
5,302
3,709
6,224
3,183
5,038
2,755
5,090
2,166
4,161
2,885
4,253
2,861
4,482
3,070
3,762
4,242
6,400
4,418
3,154
5,543
46,363
30,221
3,407
7,400
7,655
11,951
8,207
8,207
8,2078,20711,9517,6557,4003,40730,22146,3635,5433,1544,4186,4004,2423,7623,0704,4822,8614,2532,8854,1612,1665,0902,7555,0383,1836,2243,7095,3024,5783,6363,7333,6112,9443,0092,0052,6422,2562,5431,9531,1561,0004947417277685153219121,0379481,2721,2434433363538273423302641262718312617264232544752315340693446084569032402839304814754792129253743236384394865606172621043881,5299517803001002003002002002000
   > Long-term Liabilities 
0
0
0
100
100
100
100
200
382
385
447
829
844
939
996
1,146
1,167
1,410
1,213
1,221
1,141
928
766
593
556
599
571
545
555
571
644
649
683
730
729
741
761
790
798
0
859
878
939
946
1,012
1,047
1,087
1,103
1,159
1,141
1,152
1,142
1,112
1,093
1,128
1,179
1,209
1,237
1,280
1,284
1,318
1,355
1,381
1,381
1,396
1,432
1,471
986
986
986
99
895
527
777
901
850
813
1,027
1,014
1,000
1,000
1,000
1,000
1,000
1,000
1,000
22
2,612
2,450
21
99,187
115,525
117,780
120,127
122,750
125,127
130,930
133,641
136,276
141,687
146,817
149,268
151,668
154,422
113,397
111,173
118,919
109,965
76,076
20,722
21,602
34,825
36,571
39,220
40,371
44,341
62,538
53,395
53,395
53,39553,39562,53844,34140,37139,22036,57134,82521,60220,72276,076109,965118,919111,173113,397154,422151,668149,268146,817141,687136,276133,641130,930125,127122,750120,127117,780115,52599,187212,4502,612221,0001,0001,0001,0001,0001,0001,0001,0141,027813850901777527895999869869861,4711,4321,3961,3811,3811,3551,3181,2841,2801,2371,2091,1791,1281,0931,1121,1421,1521,1411,1591,1031,0871,0471,01294693987885907987907617417297306836496445715555455715995565937669281,1411,2211,2131,4101,1671,146996939844829447385382200100100100100000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124
87
50
13
0
0
0
0
0
0
0
0
0
0
0
0
99,162
115,499
117,754
120,074
122,461
124,917
127,444
130,043
132,717
138,131
143,327
145,870
148,315
151,095
110,150
107,984
0
105,828
56,325
49,624
0
32,289
0
0
0
0
0
0
0
000000032,289049,62456,325105,8280107,984110,150151,095148,315145,870143,327138,131132,717130,043127,444124,917122,461120,074117,754115,49999,16200000000000013508712400000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
849
748
811
785
718
161
587
550
593
564
520
530
530
597
649
683
729
729
741
761
790
798
843
859
878
939
947
1,012
1,048
1,086
1,103
1,158
1,141
1,152
1,142
1,112
1,093
1,128
1,179
1,209
1,236
1,280
1,283
1,318
1,355
1,381
1,380
1,396
1,432
1,471
986
986
0
0
0
527
776
777
763
763
1,014
1,014
1,000
1,000
1,000
1,000
1,000
1,000
1,000
22
0
0
21
25
26
26
53
46
35
28
19
93
190
259
335
453
580
678
808
805
757
979
1,537
0
1,097
2,158
0
0
0
0
0
0
0000002,1581,09701,5379797578058086785804533352591909319283546532626252100221,0001,0001,0001,0001,0001,0001,0001,0141,0147637637777765270009869861,4711,4321,3961,3801,3811,3551,3181,2831,2801,2361,2091,1791,1281,0931,1121,1421,1521,1411,1581,1031,0861,0481,01294793987885984379879076174172972968364959753053052056459355058716171878581174884900000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
1,000
22
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000221,0001,0001,00000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
1,000
1,400
1,900
2,200
8,500
8,900
9,200
10,021
11,520
12,678
12,356
12,330
12,400
12,263
12,236
12,049
11,961
11,401
11,262
11,070
10,712
10,361
9,612
9,352
11,453
13,226
13,745
13,524
13,337
13,219
12,729
12,306
11,932
11,554
11,737
11,227
10,912
10,349
9,668
8,914
8,128
7,353
6,739
6,207
5,765
5,296
4,880
4,411
4,091
4,549
4,413
4,284
4,161
3,983
3,894
3,492
3,119
3,094
4,910
4,986
4,963
4,845
4,815
4,658
4,350
4,021
14,836
13,439
12,068
30,093
27,524
44,994
41,517
38,809
78,704
72,277
65,991
58,822
49,350
40,187
133,018
119,661
105,041
91,183
77,816
69,133
142,034
129,924
118,704
106,475
94,886
77,406
57,375
42,968
26,005
10,220
-7,379
-22,942
-36,990
-49,668
-62,812
-66,364
-69,750
-39,747
-35,071
-56,776
-61,964
-9,797
-22,264
-38,725
-38,663
-35,033
-19,888
-25,780
-34,887
-48,481
-56,040
-56,040
-56,040-56,040-48,481-34,887-25,780-19,888-35,033-38,663-38,725-22,264-9,797-61,964-56,776-35,071-39,747-69,750-66,364-62,812-49,668-36,990-22,942-7,37910,22026,00542,96857,37577,40694,886106,475118,704129,924142,03469,13377,81691,183105,041119,661133,01840,18749,35058,82265,99172,27778,70438,80941,51744,99427,52430,09312,06813,43914,8364,0214,3504,6584,8154,8454,9634,9864,9103,0943,1193,4923,8943,9834,1614,2844,4134,5494,0914,4114,8805,2965,7656,2076,7397,3538,1288,9149,66810,34910,91211,22711,73711,55411,93212,30612,72913,21913,33713,52413,74513,22611,4539,3529,61210,36110,71211,07011,26211,40111,96112,04912,23612,26312,40012,33012,35612,67811,52010,0219,2008,9008,5002,2001,9001,4001,0000
   Common Stock
0
0
0
0
0
0
0
0
8,219
8,579
8,579
8,543
8,438
8,438
8,388
8,353
8,305
8,305
8,305
8,302
8,291
8,200
8,198
8,199
8,184
10,429
12,353
12,342
12,717
12,342
12,378
12,488
12,582
12,582
12,863
12,863
12,863
12,863
12,863
12,863
12,878
12,878
12,878
12,878
12,878
9,971
12,878
12,878
12,878
12,878
13,678
13,804
13,804
13,804
13,804
13,804
13,970
13,804
14,139
14,139
14,139
14,139
14,139
14,333
14,333
14,333
14,333
22,986
23,086
25
39
39
41
42
42
45
45
45
45
45
45
51
51
51
51
52
52
55
55
56
54
54
54
54
54
55
55
55
55
56
57
58
60
61
65
68
69
80
97
97
100
14
14
14
21
24
25
0
0
00252421141414100979780696865616058575655555555545454545456555552525151515145454545454542424139392523,08622,98614,33314,33314,33314,33314,13914,13914,13914,13914,13913,80413,97013,80413,80413,80413,80413,80413,67812,87812,87812,87812,8789,97112,87812,87812,87812,87812,87812,86312,86312,86312,86312,86312,86312,58212,58212,48812,37812,34212,71712,34212,35310,4298,1848,1998,1988,2008,2918,3028,3058,3058,3058,3538,3888,4388,4388,5438,5798,5798,21900000000
   Retained Earnings Total Equity0000000-656,769-624,034-592,630-592,439-576,7340-570,668-547,865-538,879-517,205-492,966-474,054-455,297-436,067-414,653-393,318-372,884-352,069-330,348-308,156-286,058-262,833-241,972-225,676-208,601-192,144-177,289-161,154-143,855-125,989-110,915-97,752-86,566-74,314-65,41700000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
-200
-200
-200
-200
-200
-200
-100
-274
-274
-274
-162
-274
-274
-274
-240
-259
-278
-292
-309
-309
-309
-274
-28
-28
-274
-28
-49
-274
375
375
375
281
281
-111
-102
-102
-102
-102
-172
-274
-172
-274
-274
-274
-274
-274
-274
-274
-274
-274
-274
-274
-303
0
-326
0
0
0
-337
-337
0
0
-339
-339
0
0
-337
-274
0
0
0
11
22
26
28
11
7
12
3
1
-12
-9
69
-9
-204
-137
3
87
-6,584
59
-134
-159
-149
-104
44
-59
-58
150
140
94
91
-9
13
-17
-60
-232
-432
-245
-400
-631
-653
-360
-612
-618
-449
-1,057
-6
-6
-6-6-1,057-449-618-612-360-653-631-400-245-432-232-60-1713-99194140150-58-5944-104-149-159-13459-6,584873-137-204-969-9-12131271128262211000-274-33700-339-33900-337-337000-3260-303-274-274-274-274-274-274-274-274-274-274-274-172-274-172-102-102-102-102-111281281375375375-274-49-28-274-28-28-274-309-309-309-292-278-259-240-274-274-274-162-274-274-274-100-200-200-200-200-200-2000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,519
1,535
1,594
7,925
8,093
0
51,805
53,013
74,266
75,937
78,427
126,469
128,873
131,356
133,079
135,868
137,893
243,894
245,608
248,776
252,295
255,257
261,362
350,577
355,458
360,620
414,262
426,091
430,734
432,885
440,154
443,857
448,609
452,344
457,987
463,178
469,302
475,072
495,857
514,122
553,134
580,652
0
560,185
627,853
627,853
630,903
663,812
0
0
0
0
0
0
0
0000000663,812630,903627,853627,853560,1850580,652553,134514,122495,857475,072469,302463,178457,987452,344448,609443,857440,154432,885430,734426,091414,262360,620355,458350,577261,362255,257252,295248,776245,608243,894137,893135,868133,079131,356128,873126,46978,42775,93774,26653,01351,80508,0937,9251,5941,5351,5190000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000-45,0670-45,0670-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067-45,067000000000000000000000-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-274-273-274-274-274-274-274-274-274-274-274-274-273-274-273-274-273-274-274-274-274-274-274-274-27400000000000000000
   Other Stockholders Equity 
0
2,000
2,000
2,000
2,000
8,300
8,300
8,400
315
315
315
204
315
315
315
281
300
41
41
0
41
41
315
0
41
315
41
481
332
75
94
271
271
268
226
290
187
187
187
0
212
212
13,379
13,448
13,456
13,470
13,477
13,513
13,532
13,551
703
14,726
14,822
775
806
14,975
688
864
15,004
15,022
15,031
15,034
15,041
0
15,579
15,595
15,654
7,651
16,846
31,244
51,805
53,013
74,266
75,937
78,427
126,469
128,873
131,356
133,079
135,868
137,893
243,894
245,608
248,776
252,295
255,257
261,362
350,577
355,458
360,620
369,195
381,024
385,667
387,818
395,087
398,790
403,542
407,277
412,920
418,111
424,235
430,005
450,790
469,055
508,067
535,585
502,314
515,118
582,786
585,274
585,836
611,990
621,172
649,567
657,904
660,213
661,864
-56,034
-56,034
-56,034-56,034661,864660,213657,904649,567621,172611,990585,836585,274582,786515,118502,314535,585508,067469,055450,790430,005424,235418,111412,920407,277403,542398,790395,087387,818385,667381,024369,195360,620355,458350,577261,362255,257252,295248,776245,608243,894137,893135,868133,079131,356128,873126,46978,42775,93774,26653,01351,80531,24416,8467,65115,65415,59515,579015,04115,03415,03115,02215,00486468814,97580677514,82214,72670313,55113,53213,51313,47713,47013,45613,44813,37921221201871871872902262682712719475332481413154103154141041413002813153153152043153153158,4008,3008,3002,0002,0002,0002,0000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue11,698
Cost of Revenue-8,994
Gross Profit2,7042,704
 
Operating Income (+$)
Gross Profit2,704
Operating Expense-38,014
Operating Income-35,310-35,310
 
Operating Expense (+$)
Research Development16,688
Selling General Administrative21,326
Selling And Marketing Expenses0
Operating Expense38,01438,014
 
Net Interest Income (+$)
Interest Income703
Interest Expense-13,117
Other Finance Cost-0
Net Interest Income-12,414
 
Pretax Income (+$)
Operating Income-35,310
Net Interest Income-12,414
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-50,111-20,509
EBIT - interestExpense = -50,111
-50,111
-36,928
Interest Expense13,117
Earnings Before Interest and Taxes (EBIT)-36,994-36,994
Earnings Before Interest and Taxes (EBITDA)-33,573
 
After tax Income (+$)
Income Before Tax-50,111
Tax Provision--66
Net Income From Continuing Ops-50,045-50,045
Net Income-50,045
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses47,008
Total Other Income/Expenses Net-14,80112,414
 

Technical Analysis of Accelerate Diagnostics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Accelerate Diagnostics Inc. The general trend of Accelerate Diagnostics Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Accelerate Diagnostics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Accelerate Diagnostics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Accelerate Diagnostics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.49 < 0.5899 < 0.73.

The bearish price targets are: .

Know someone who trades $AXDX? Share this with them.πŸ‘‡

Accelerate Diagnostics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Accelerate Diagnostics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Accelerate Diagnostics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Accelerate Diagnostics Inc. The current macd is -0.16921653.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Accelerate Diagnostics Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Accelerate Diagnostics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Accelerate Diagnostics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Accelerate Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAccelerate Diagnostics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Accelerate Diagnostics Inc. The current adx is 37.80.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Accelerate Diagnostics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Accelerate Diagnostics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Accelerate Diagnostics Inc. The current sar is 0.38458374.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Accelerate Diagnostics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Accelerate Diagnostics Inc. The current rsi is 13.15. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Accelerate Diagnostics Inc Daily Relative Strength Index (RSI) ChartAccelerate Diagnostics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Accelerate Diagnostics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Accelerate Diagnostics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Accelerate Diagnostics Inc Daily Stochastic Oscillator ChartAccelerate Diagnostics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Accelerate Diagnostics Inc. The current cci is -137.36843039.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Accelerate Diagnostics Inc Daily Commodity Channel Index (CCI) ChartAccelerate Diagnostics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Accelerate Diagnostics Inc. The current cmo is -79.28442619.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Accelerate Diagnostics Inc Daily Chande Momentum Oscillator (CMO) ChartAccelerate Diagnostics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Accelerate Diagnostics Inc. The current willr is -95.20429363.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Accelerate Diagnostics Inc Daily Williams %R ChartAccelerate Diagnostics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Accelerate Diagnostics Inc. The current atr is 0.07369924.

Accelerate Diagnostics Inc Daily Average True Range (ATR) ChartAccelerate Diagnostics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Accelerate Diagnostics Inc. The current obv is -93,611,667.

Accelerate Diagnostics Inc Daily On-Balance Volume (OBV) ChartAccelerate Diagnostics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Accelerate Diagnostics Inc. The current mfi is 0.10505548.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Accelerate Diagnostics Inc Daily Money Flow Index (MFI) ChartAccelerate Diagnostics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Accelerate Diagnostics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-12-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-26MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-05-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Accelerate Diagnostics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Accelerate Diagnostics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5013.153
Ma 20Greater thanMa 500.402
Ma 50Greater thanMa 1000.679
Ma 100Greater thanMa 2000.928
OpenGreater thanClose0.015
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Accelerate Diagnostics Inc with someone you think should read this too:
  • Are you bullish or bearish on Accelerate Diagnostics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Accelerate Diagnostics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Accelerate Diagnostics Inc

I send you an email if I find something interesting about Accelerate Diagnostics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Accelerate Diagnostics Inc.

Receive notifications about Accelerate Diagnostics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.